Table 3 Univariate and multivariate analysis of prognostic factors in the cStage III, IVa ESCC treated with NAC
From: Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma
Variable | 36 months RFS Univariate | p-value | 36 months RFS Multivariate | p-value | ||
|---|---|---|---|---|---|---|
Hazard ratio | (95% CI) | Hazard ratio | (95% CI) | |||
CD20 (high/low) | 0.804 | (0.442–1.462) | 0.4744 | 1.176 | (0.602–2.296) | 0.6355 |
CD8 (high/low) | 0.664 | (0.342–1.291) | 0.2276 | 0.664 | (0.325–1.358) | 0.2618 |
CD23 (high/low) | 0.450 | (0.219–0.922) | 0.0292* | 0.437 | (0.206–0.924) | 0.0302* |